Bcl-2 family members either promote or repress programmed cell death. Bax, a death-promoting member, is a pore-forming, mitochondria-associated protein whose mechanism of action is still unknown. During apoptosis, cytochrome C is released from the mitochondria into the cytosol where it binds to APAF-1, a mammalian homologue of Ced-4, and participates in the activation of caspases. The release of cytochrome C has been postulated to be a consequence of the opening of the mitochondrial permeability transition pore (PTP). We now report that Bax is sufficient to trigger the release of cytochrome C from isolated mitochondria. This pathway is distinct from the previously described calcium-inducible, cyclosporin A–sensitive PTP. Rather, the cytochrome C release induced by Bax is facilitated by Mg2+ and cannot be blocked by PTP inhibitors. These results strongly suggest the existence of two distinct mechanisms leading to cytochrome C release: one stimulated by calcium and inhibited by cyclosporin A, the other Bax dependent, Mg2+ sensitive but cyclosporin insensitive.
Skip Nav Destination
Article navigation
5 October 1998
Article|
October 05 1998
Bax-induced Cytochrome C Release from Mitochondria Is Independent of the Permeability Transition Pore but Highly Dependent on Mg2+ Ions
Robert Eskes,
Robert Eskes
*Serono Pharmaceutical Research Institute, 1228 Plan-les-Ouates, Geneva, Switzerland; and ‡ ETH Laboratory of Biochemistry, 8092 Zurich, Switzerland
Search for other works by this author on:
Bruno Antonsson,
Bruno Antonsson
*Serono Pharmaceutical Research Institute, 1228 Plan-les-Ouates, Geneva, Switzerland; and ‡ ETH Laboratory of Biochemistry, 8092 Zurich, Switzerland
Search for other works by this author on:
Astrid Osen-Sand,
Astrid Osen-Sand
*Serono Pharmaceutical Research Institute, 1228 Plan-les-Ouates, Geneva, Switzerland; and ‡ ETH Laboratory of Biochemistry, 8092 Zurich, Switzerland
Search for other works by this author on:
Sylvie Montessuit,
Sylvie Montessuit
*Serono Pharmaceutical Research Institute, 1228 Plan-les-Ouates, Geneva, Switzerland; and ‡ ETH Laboratory of Biochemistry, 8092 Zurich, Switzerland
Search for other works by this author on:
Christoph Richter,
Christoph Richter
*Serono Pharmaceutical Research Institute, 1228 Plan-les-Ouates, Geneva, Switzerland; and ‡ ETH Laboratory of Biochemistry, 8092 Zurich, Switzerland
Search for other works by this author on:
Rémy Sadoul,
Rémy Sadoul
*Serono Pharmaceutical Research Institute, 1228 Plan-les-Ouates, Geneva, Switzerland; and ‡ ETH Laboratory of Biochemistry, 8092 Zurich, Switzerland
Search for other works by this author on:
Gonzalo Mazzei,
Gonzalo Mazzei
*Serono Pharmaceutical Research Institute, 1228 Plan-les-Ouates, Geneva, Switzerland; and ‡ ETH Laboratory of Biochemistry, 8092 Zurich, Switzerland
Search for other works by this author on:
Anthony Nichols,
Anthony Nichols
*Serono Pharmaceutical Research Institute, 1228 Plan-les-Ouates, Geneva, Switzerland; and ‡ ETH Laboratory of Biochemistry, 8092 Zurich, Switzerland
Search for other works by this author on:
Jean-Claude Martinou
Jean-Claude Martinou
*Serono Pharmaceutical Research Institute, 1228 Plan-les-Ouates, Geneva, Switzerland; and ‡ ETH Laboratory of Biochemistry, 8092 Zurich, Switzerland
Search for other works by this author on:
Robert Eskes
*Serono Pharmaceutical Research Institute, 1228 Plan-les-Ouates, Geneva, Switzerland; and ‡ ETH Laboratory of Biochemistry, 8092 Zurich, Switzerland
Bruno Antonsson
*Serono Pharmaceutical Research Institute, 1228 Plan-les-Ouates, Geneva, Switzerland; and ‡ ETH Laboratory of Biochemistry, 8092 Zurich, Switzerland
Astrid Osen-Sand
*Serono Pharmaceutical Research Institute, 1228 Plan-les-Ouates, Geneva, Switzerland; and ‡ ETH Laboratory of Biochemistry, 8092 Zurich, Switzerland
Sylvie Montessuit
*Serono Pharmaceutical Research Institute, 1228 Plan-les-Ouates, Geneva, Switzerland; and ‡ ETH Laboratory of Biochemistry, 8092 Zurich, Switzerland
Christoph Richter
*Serono Pharmaceutical Research Institute, 1228 Plan-les-Ouates, Geneva, Switzerland; and ‡ ETH Laboratory of Biochemistry, 8092 Zurich, Switzerland
Rémy Sadoul
*Serono Pharmaceutical Research Institute, 1228 Plan-les-Ouates, Geneva, Switzerland; and ‡ ETH Laboratory of Biochemistry, 8092 Zurich, Switzerland
Gonzalo Mazzei
*Serono Pharmaceutical Research Institute, 1228 Plan-les-Ouates, Geneva, Switzerland; and ‡ ETH Laboratory of Biochemistry, 8092 Zurich, Switzerland
Anthony Nichols
*Serono Pharmaceutical Research Institute, 1228 Plan-les-Ouates, Geneva, Switzerland; and ‡ ETH Laboratory of Biochemistry, 8092 Zurich, Switzerland
Jean-Claude Martinou
*Serono Pharmaceutical Research Institute, 1228 Plan-les-Ouates, Geneva, Switzerland; and ‡ ETH Laboratory of Biochemistry, 8092 Zurich, Switzerland
Address all correspondence to J.-C. Martinou, Serono Pharmaceutical Research Institute, 14 Chemin des Aux, 1228 Plan les Ouates, Geneva, Switzerland. Tel.: (41) 22 706 9822. Fax: (41) 22 794 6965. E-mail: [email protected]
Received:
July 15 1998
Revision Received:
August 27 1998
Online ISSN: 1540-8140
Print ISSN: 0021-9525
1998
J Cell Biol (1998) 143 (1): 217–224.
Article history
Received:
July 15 1998
Revision Received:
August 27 1998
Citation
Robert Eskes, Bruno Antonsson, Astrid Osen-Sand, Sylvie Montessuit, Christoph Richter, Rémy Sadoul, Gonzalo Mazzei, Anthony Nichols, Jean-Claude Martinou; Bax-induced Cytochrome C Release from Mitochondria Is Independent of the Permeability Transition Pore but Highly Dependent on Mg2+ Ions . J Cell Biol 5 October 1998; 143 (1): 217–224. doi: https://doi.org/10.1083/jcb.143.1.217
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionEmail alerts
Advertisement
Advertisement